Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members

Journal of Neurochemistry

Volumn 105, Issue 6, 2008, Pages 2091-2097

  Fei, Qingyan ^a   Ethell, Douglas W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Bak; Bax; Bik; Bim; MPTP

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BCL2 RELATED PROTEIN A1; BIM PROTEIN; CYTOCHROME C; MANEB; PARAQUAT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN P53; SMALL INTERFERING RNA;

ARTICLE; CELL DEATH; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION;

BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CELL DEATH; CELL LINE, TUMOR; DRUG SYNERGISM; HERBICIDES; HUMANS; MANEB; MULTIGENE FAMILY; PARAQUAT; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 44649181084     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05293.x     Document Type: Article

References (36)

1. Braak H., Del Tredici K., Rueb U., de Vos R. A. I., Jansen Steur E. N. H. Braak E. (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197 211.
2. Braak H., Bohl J. R., Mueller C. M., Rueb U., de Vos R. A. I. Del Tredici K. (2005) Stanley Fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov. Disord. 21, 2042 2051.
3. Brown T. P., Rumsby P. C., Capleton A. C., Rushton L. Levy L. S. (2005) Pesticides and Parkinson's disease - is there a link? Env. Health Persp. 114, 156 164.
4. Burkitt M. J., Kadiiska M. B., Hanna P. M., Jordan S. J. Mason R. P. (1993) Electron spin resonance spin-trapping investigation into the effects of paraquat and desferrioxamine on hydroxyl radical generation during acute iron poisoning. Mol. Pharmacol. 43, 257 263.
5. Bus J. S. Gibson J. E. (1984) Paraquat: model for oxidant-initiated toxicity. Environ. Health Perspect. 55, 37 46.
6. Clejan L. Cederbaum A. I. (1989) Synergistic interactions between NADPH-cytochrome P-450 reductase, paraquat, and iron in the generation of active oxygen radicals. Biochem. Pharmacol. 38, 1779 1786.
7. Fei Q., McCormack A. L., Di Monte D. A. Ethell D. W. (2008) Paraquat neurotoxicity is mediated by BNip3 and Noxa activation of Bak. J. Biol. Chem. 283, 3357 3364.
8. Fitsanakis V. A., Amarnath V., Moore J. T., Montine K. S., Zhang J. Montine T. J. (2002) Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides. Free Radic. Biol. Med. 33, 1714 1723.
9. Gainetdinov R. R., Fumagalli F., Jones S. R. Caron M. G. (1997) Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. J. Neurochem. 69, 1322 1325.
10. Langston J. W., Ballard P., Tetrud J. W. Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979 980.
11. Liou H. H., Tsai M. C., Chen C. J., Jeng J. S., Chang Y. C., Chen S. Y. Chen R. C. (1997) Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology 48, 1583 1588.
12. McCormack A. L., Atienza J. G., Johnston L. C., Andersen J. K., Vu S. DiMonte D. A. (2005) Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J. Neurochem. 93, 1030 1037.
13. McGrew D. M., Irwin I. Langston J. W. (2000) Ethylenebisdithiocarbamate enhances MPTP-induced striatal dopamine depletion in mice. Neurotoxicology 21, 309 312.
14. +, a metabolite of the neurotoxin MPTP. Life Sci. 36, 2503 2508.
15. Norris E. H., Uryu K., Leigth S., Giasson B. I., Trojanowski J. Q. Lee V. M.-Y. (2007) Pesticide exposure exacerbates α-synucleinopathy in an A53T transgenic mouse model. Am. J. Pathol. 170, 658 666.
16. Peng J., Mao X. O., Stevenson F. F., Hsu M. Andersen J. K. (2004) The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J. Biol. Chem. 279, 32626 32632.
17. Peng J., Stevenson F. F., Doctrow S. R. Andersen J. K. (2005) Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J. Biol. Chem. 280, 29194 29198.
18. Perier C., Tieu K., Guégan C., Caspersen C., Jackson-Lewis V., Carelli V., Martinuzzi A., Hirano M., Przedborski S. Vila M. (2005) Complex I deficiency primes Bax-dependent neuronal apoptosis through mitochondrial oxidative damage. Proc. Natl Acad. Sci. USA 102, 19126 19131.
19. Perier C., Bové J., Wu D. C. et al. (2007) Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease. Proc. Natl Acad. Sci. USA 104, 8161 8166.
20. Przedborski S., Jackson-Lewis V., Kostic V., Carlson E., Epstein C. J. Cadet J. L. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to MPTP neurotoxicity. J. Neurosci. 12, 1658 1667.
21. Przedborski S., Tieu K., Perier C. Vila M. (2004) MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36, 375 379.
22. +, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol. Sci. 95, 163 171.
23. Richardson J. R., Quan Y., Sherer T. B., Greenamyre J. T. Miller G. W. (2005) Paraquat neurotoxicity is distinct from that of MPTP and rotenone. Toxicol. Sci. 88, 193 201.
24. Ruiz-Vela A., Opferman J. T., Cheng E. H. Korsmeyer S. J. (2005) Proapoptotic BAX and BAK control multiple initiator caspases. EMBO Rep. 6, 379 385.
25. Saporito M. S., Brown E. M., Miller M. S. Carswell S. (1999) CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo. J. Pharmacol. Exp. Ther. 288, 421 427.
26. Saporito M. S., Thomas B. A. Scott R. W. (2000) MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75, 1200 1208.
27. Semchuk K. M., Love E. J. Lee R. G. (1992) Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 42, 1328 1335.
28. Simmons M. J., Fan G., Zong W. X., Degenhardt K., White E. Gélinas C. (2007) Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Oncogene [Epub ahead of print]
29. Thiruchelvam M., Brockel B. J., Richfield E. K., Baggs R. B. Cory-Slechta D. A. (2000a) Potentiated and preferential effects of combined paraquat and maneb on nigrostriatal dopamine systems: environmental risk factors for Parkinson's disease? Brain Res. 873, 225 234.
30. Thiruchelvam M., Richfield E. K., Baggs R. B., Tank A. W. Cory-Slechta D. A. (2000b) The nigrostriatal dopaminergic system as a preferential target of repeated exposures to combined paraquat and maneb: implications for Parkinson's disease. J. Neurosci. 20, 9207 9214.
31. Thiruchelvam M., Prokopenko O., Cory-Slechta D. A., Richfield E. K., Buckley B. Mirochnitchenko O. (2005) Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat + maneb-induced Parkinson disease phenotype. J. Biol. Chem. 2005 (280 22530 22539.
32. Vila M., Jackson-Lewis V., Vukosavic S., Djaldetti R., Liberatore G., Offen D., Korsmeyer S. J. Przedborski S. (2001) Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. Proc. Natl Acad. Sci. USA 98, 2837 2842.
33. Wei M. C., Zong W. X., Cheng E. H., Lindsten T., Panoutsakopoulou V., Ross A. J., Roth K. A., MacGregor G. R., Thompson C. B. Korsmeyer S. J. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292, 727 730.
34. Willis S. N., Chen L., Dewson G., Wei A., Naik E., Fletcher J. I., Adams J. M. Huang D. C. (2005) Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 19, 1294 1305.
35. Willis S. N., Fletcher J. I., Kaufmann T. et al. (2007) Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315, 856 859.
36. Zhou Y., Shie F. S., Piccardo P., Montine T. J. Zhang J. (2004) Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease. Neuroscience 128, 281 291.